'Structure, beauty and clarity': With seed financing, Kaleidoscope aims to synchronize R&D teams
High school friends Bogdan Knezevic and Ahmed Elnaiem kept in touch in the years following graduation, and about a decade later found themselves hopping on calls every week to “catch up and riff on things.”
Knezevic, after working on a clinical medicine PhD at Oxford and taking a summer stint at Frequency Therapeutics, became annoyed by the siloed nature of drug R&D.
“The crux of my frustration was the amount of time I was wasting and spending not doing science,” Knezevic told Endpoints News, speaking of his venting-and-catching-up calls with Elnaiem, who’d been working his way through multiple product engineering roles at a series of startups and Google.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.